New York is expected to take the lead on financial sector regulations and push for mandatory risk disclosures from large AI ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

Strategic and disciplined execution underway to embed Bitcoin-backed capital into Rezolve’s AI commerce platform through ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...